Search Results - "Bonichon, N"

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer by Mineur, L, François, E, Plassot, C, Phelip, J M, Miglianico, L, Dourthe, L M, Bonichon, N, Moreau, L, Guimbaud, R, Smith, D, Achille, E, Hervé, R, Bons, J M, Remy, S, Faroux, R, Villing, A L, Mahamat, A, Rabbia, I, Soulié, P, Baumgaertner, I, Mathé, N, Vazquez, L, Boustany, R

“…Cetuximab improves progression-free survival (PFS) and overall survival (OS) in patients with KRAS wild type (wt) metastatic colorectal cancer (mCRC). Few data…”
Get full text

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1 by Berger, Frédérique, Marce, Margaux, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Bièche, Ivan, Pradines, Anne, De La Motte Rouge, Thibault, Canon, Jean-Luc, André, Fabrice, Clatot, Florian, Lemonnier, Jérôme, Marques, Sandrine, Bidard, François-Clement, Achille, M, Alleaume, C, Ammarguellat, H, Arsene, O, Bachelot, T, Barthelemy, P, Barthier, S, Bernard-Marty, C, Bonichon-Lamichhane, N, Bonnin, N, Bouaita, R, Boudrant, A, Brunel, V-A, Chakiba, C, Cheneau, C, Clatot, F, Dalenc, F, De Gramont, A, de La Motte Rouge, T, Deiana, L, Del Piano, F, Delbaldo, C, Delecroix, V, Derbel, O, Desclos, H, D'Hondt, V, Dohollou, N, Dubot, C, Escande, A, Ferrero, J-M, Foa, C, Frenel, J-S, Gardner, M, Garnier Tixidre, C, Genet, D, Gisserot, O, Gozy, M, Greilsamer, C, Grenier, J, Guinet, F, Hardy-Bessard, A-C, Jacquin, J-P, Joly, L, Lachaier, E, Ladoire, S, Laurenty, A-P, Le Scodan, R, Leduc, N, Levache, C, Lorchel, F, Lortholary, A, Lucas, B, Marques, N, Marti, A, Melis, A, Mille, D, Mollon, D, Moreau, L, Moullet, I, Mouret-Reynier, M-A, Najem, A, Nguyen, S, Orfeuvre, H, Paitel, J-F, Petit, T, Pistilli, B, Plaza, J, Riedl, C, Sabatier, R, Soulie, P, Spaeth, D, Stefani, L, Teixeira, L, Trouboul, F, Valmar, C, Vegas, H, Venat-Bouvet, L, Zannetti, A, Bidard, FC, Delaloge, S, Bièche, I, Clatot, Florian, Canon, JL, André, F, Arnould, L, Berger, F, Marques, S

“…IntroductionThe combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) has recently become the gold standard for AI-sensitive first line treatment…”
Get full text

PP 86 Immunohistochemistry and molecular biology of the PI3K pathway did not correlate with treatment efficacy of everolimus as second line or third line treatment of advanced endometrial carcinoma by Tredan, O, Pissaloux, D, Treilleux, I, Wanq, Q, Bonichon-Lamichhane, N, Mari, V, Freyer, G, Pujade-Lauraine, E, Ray-Coquard, I

Get full text

A bijection between realizers of maximal plane graphs and pairs of non-crossing Dyck paths by Bonichon, Nicolas

“…Schnyder trees, or realizers, of maximal plane graphs, are widely used in the graph drawing domain. In this paper, a bijection between realizers and pairs of…”
Get full text

Asymptotics of geometrical navigation on a random set of points in the plane by Bonichon, Nicolas, Marckert, Jean-François

“…A navigation on a set of points S is a rule for choosing which point to move to from the present point in order to progress toward a specified target. We study…”
Get full text

Les enjeux du vécu de la radiothérapie : perspectives pour un meilleur accompagnement des malades by Dilhuydy, J.M, Hoarau, H

“…L’analyse du vécu de la radiothérapie montre bien la nature des épreuves multiples auxquelles sont brutalement confrontés les patients : épreuves d’un espace…”
Get full text

Radiothérapie fractionnée des méningiomes et des neurinomes intracrâniens by MAIRE, J. P, VENDRELY, V, DAUTHERIBES, M, BONICHON, N, DARROUZET, V

Get full text

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial by Kurtz, Jean-Emmanuel, Pujade-Lauraine, Eric, Oaknin, Ana, Belin, Lisa, Leitner, Katharina, Cibula, David, Denys, Hannelore, Rosengarten, Ora, Rodrigues, Manuel, de Gregorio, Nikolaus, Martinez García, Jeronimo, Petru, Edgar, Kocián, Roman, Vergote, Ignace, Pautier, Patricia, Schmalfeldt, Barbara, Gaba, Lydia, Polterauer, Stephan, Mouret Reynier, Marie-Ange, Sehouli, Jalid, Churruca, Cristina, Selle, Frédéric, Joly, Florence, D'Hondt, Véronique, Bultot-Boissier, Émilie, Lebreton, Coriolan, Lotz, Jean-Pierre, Largillier, Rémy, Heudel, Pierre-Etienne, Heitz, Florian

“…Platinum-based doublets with concurrent and maintenance bevacizumab are standard therapy for ovarian cancer (OC) relapsing after a platinum-free interval (PFI)…”
Get full text

1204MO PRODIGE 59 - DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma by Tougeron, D., Dahan, L., El Hajbi, F., Le Malicot, K., Evesque, L., Aparicio, T., Bouche, O., Bonichon Lamichhane, N., Chibaudel, B., Angelergues, A., A. bodere, Phelip, J.M., Mabro, M., Artru, P., Louvet, C.

Get full text

Watermelon uniform random generation with applications by Bonichon, Nicolas, Mosbah, Mohamed

“…Watermelons are particular configurations of vicious walkers. In these configurations, each path starts and ends at the same ordinate. We present a simple…”
Get full text

Adjuvant chemotherapy with or without atezolizumab for stage II and III triple-negative breast cancer: final analysis of the ALEXANDRA/ IMpassion030 phase 3 trial by McArthur, H., Bailey, A., Saji, S., El-Abed, S., Nader Marta, G., Metzger, O., Seiller, A., Shparyk, Y., Kim, H.J., Bonichon Lamichhane, N., Alonso, J.L., Ellingson, A., Zimina, A., Yamashita, T., Mohan, S., Shao, Z., Viale, G., Piccart, M., Ignatiadis, M., Gelber, R.

Get full text

Modeling and Practical Evaluation of a Service Location Problem in Large Scale Networks by Beaumont, O., Bonichon, N., Larchevêque, H.

“…We consider a generalization of a classical optimization problem related to server and replica location problems in networks. More precisely, we suppose that a…”
Get full text

Les dysgerminomes du système nerveux central. Expérience du centre hospitalier universitaire de Bordeaux et analyse de la littérature by Bonichon, N., San Galli, F., Pérel, Y., Trouette, R., Dahan, O., Dautheribes, M., Maire, J.P., Guérin, J., Caudry, M.

“…Analyse rétrospective des dossiers de 17 patients atteints de tumeur germinale du système nerveux central, traités au sein d'une consultation…”
Get full text

Broadcasting on Large Scale Heterogeneous Platforms with Connectivity Artifacts under the Bounded Multi-port Model by Beaumont, O., Bonichon, N., Eyraud-Dubois, L., Uznanski, P.

“…We consider the classical problem of broadcasting a large message at an optimal rate in a large scale distributed network. The main novelty of our approach is…”
Get full text

LBA21 Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial by Borg, C., Rullier, E., Marchal, F., Etienne, P-L., Rio, E., Francois, E., Mesgouez-Nebout, N., Vendrely, V., Artignan, X., Bouche, O., Gargot, D., Boige, V., Bonichon-Lamichhane, N., Louvet, C., Morand, C., de la Fouchardiere, C., Juzyna, B., Mollevi, C., Castan, F., Conroy, T.

Get full text

304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial by Frenel, J-S., Dalenc, F., Pistilli, B., de La Motte Rouge, T., Levy, C., Mouret-Reynier, M-A., Hardy-Bessard, A-C., Bonichon-Lamichhane, N., Greilsamer, C., Delecroix, V., Nguyen, S., Berger, F., Everhard, S., Lemonnier, J., Loirat, D., Callens, C., Pradines, A., Bachelot, T., Delaloge, S., Bidard, F.C.

Get full text

Radiothérapie fractionnée des méningiomes intracrâniens: 15 ans d'expérience au centre hospitalier universitaire de Bordeaux by Vendrely, V., Maire, J.P., Darrouzet, V., Bonichon, N., San Galli, F., Célérier, D., Causse, N., Demeaux, H., Trouette, R., Dahan, O., Récaldini, L., Guérin, J., Caudry, M.

“…Évaluer les résultats à long terme de l'irradiation fractionnée des méningiomes intracrâniens. De janvier 1981 à décembre 1996, 156 patients atteints d'un…”
Get full text

1037P - Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study by Haviari, S., Blanchet, B., Colomban, O., Venat-Bouvet, L., Dohollou, N., Floquet, A., Louvet, C., Lotz, J.-P., Lacourtoisie, S Abadie, Favier, L., Fabbro, M., Bonichon-Lamichhane, N., Kurtz, J.E., Follana, P., Leheurteur, M., Del Piano, F., Alliot, C.R., Alexandre, J., You, B., Tod, M.

“…Nintedanib is a multikinase inhibitor whose main targets are VEGFR 1/2/3, PDGFR and FGFR1. It is approved for idiopathic pulmonary fibrosis and non-small-cell…”
Get full text

Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study by Haviari, S., Blanchet, B., Colomban, O., Venat-Bouvet, L., Dohollou, N., Floquet, A., Louvet, C., Lotz, J.-P., Lacourtoisie, S Abadie, Favier, L., Fabbro, M., Bonichon-Lamichhane, N., Kurtz, J.E., Follana, P., Leheurteur, M., Del Piano, F., Alliot, C.R., Alexandre, J., You, B., Tod, M.

Get full text

1037PPost-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: A GINECO study by Haviari, S, Blanchet, B, Colomban, O, Venat-Bouvet, L, Dohollou, N, Floquet, A, Louvet, C, Lotz, J-P, Lacourtoisie, S Abadie, Favier, L, Fabbro, M, Bonichon-Lamichhane, N, Kurtz, J E, Follana, P, Leheurteur, M, Del Piano, F, Alliot, C R, Alexandre, J, You, B, Tod, M

“…Abstract Background Nintedanib is a multikinase inhibitor whose main targets are VEGFR 1/2/3, PDGFR and FGFR1. It is approved for idiopathic pulmonary fibrosis…”
Get full text